Publications

The Distribution of the EQ-5D-5L Index in Patient Populations

1 October 2016

EQ-5D data are often summarised by an EQ-5D index, whose distribution for its original version, the EQ-5D-3L, often shows two distinct groups in patient populations, arising…

Four Case Studies to Explore the Added Value of Oxford AHSN

9 January 2016

The Oxford Academic Health Science Network (Oxford AHSN) wishes to demonstrate the value of the various projects and programmes that the network has developed and implemented since it was established in 2013.

Improving Efficiency and Resource Allocation in Future Cancer Care

9 January 2016

The economic burden that cancer poses on our society is staggering – 25 million years of healthy life lost, at cost of €126 billion including €52…

How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?

8 January 2016

This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting, Tokyo. The panel session was entitled “How…

“New Age” Decision Making in HTA: Is It Applicable in Asia?

1 August 2016

This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting in Tokyo. The panel session was entitled…

Waiting Time Policies in the Health Sector

1 June 2016

This OHE Seminar Briefing summarises a seminar given by Professor Luigi Siciliani on waiting time policies in the health sector from an international perspective, and highlights…

A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications

1 May 2016

NICE’s decisions exert an influence on the allocation of fixed NHS budgets, but decisions for different types of health interventions (for example drugs and devices) are…

Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making

4 January 2016

This report details the views of a selection of experts in the fields of health and welfare economics on the cost-effectiveness threshold used by the National…

Assessing Trends in SMC Advice Decisions (October 2009- September 2015)

1 February 2016

The objective of this OHE Consulting Report was to outline trends in Scottish Medicines Committee (SMC) advice decisions for medicines for the period October 2009 to…